Publisher
Springer Berlin Heidelberg
Reference40 articles.
1. Akinla O et al. (1976) Intravaginal contraception with the synthetic progestin R2323, Contraception, 14: 671 - 678
2. Alvarez-Sanchez F et al. (1992) Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles, Contraception, 46: 387 - 398
3. Ayton RA et al. (1996) A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy, Brit. J. of Obs. & Gynae., April 1996, Vol. 103: 351-358
4. Barentsen R et al. (1997) Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy, Eur. J. of Obs. & Gynae. and Rep. Biology, 71, 73 - 80
5. Berjink EW et al. (1983) Binding of progestogens to receptor proteins in MCF-7 cells, J. Steroid Biochem. 19: 1563 - 1570